Extremely just lately, preliminary results from a third trial evaluating ibrutinib compared to observation ended up introduced.105 People obtaining ibrutinib experienced an extended occasion-cost-free survival, but no All round survival gain, Even though the final results ended up nevertheless immature. Additionally, While serious adverse gathering